#viralsuppression — Monday, February 09, 2026 (2 items)
| 0 | ℹ |
Phase 2 Trial of Long-Acting Cabotegravir and VRC07-523LS for Viral Suppression in Adults With HIV-1: ACTG A5357.
(academic.oup.com)
|
Clinical Infectious Diseases 2026-02-09 | #clinical trial #immunotherapy #hiv #viralsuppression | |
| 0 | ℹ |
Clinical Predictors and Incidence of Kaposi Sarcoma Among Males With HIV in the Treat-All Era in the United States and Canada.
(academic.oup.com)
|
Clinical Infectious Diseases 2026-02-09 | #immunosuppression #cancer #epidemiology #hiv #viralsuppression |